Epigenome-Wide Studies of Antipsychotics: A Systematic Review and Pathway Meta-Analysis

References

• Lomholt LH , AndersenDV , Sejrsgaard-JacobsenCet al. Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up. Int. J. Bipolar Disord.7(1), 6 (2019).
   PubMedGoogle Scholar
• Hofer A , MizunoY , WartelsteinerFet al. Quality of life in schizophrenia and bipolar disorder: the impact of symptomatic remission and resilience. Eur. Psychiatry46, 42–47 (2017).
   PubMed Web of Science ®Google Scholar
• Lacro JP , DunnLB , DolderCR , LeckbandSG , JesteDV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry63(10), 892–909 (2002).
   PubMed Web of Science ®Google Scholar
• Lisoway AJ , ChenCC , ZaiCC , TiwariAK , KennedyJL. Toward personalized medicine in schizophrenia: genetics and epigenetics of antipsychotic treatment. Schizophr. Res.232, 112–124 (2021).
   PubMed Web of Science ®Google Scholar
• Burghardt KJ , KhouryAS , MsallatyZ , YiZ , SeyoumB. Antipsychotic medications and DNA methylation in schizophrenia and bipolar disorder: a systematic review. Pharmacotherapy40(4), 331–342 (2020).
   PubMed Web of Science ®Google Scholar
• Guidotti A , GraysonDR. DNA methylation and demethylation as targets for antipsychotic therapy. Dialogues Clin. Neurosci.16(3), 419–429 (2014).
   PubMed Web of Science ®Google Scholar
• Wawrzczak-Bargieła A , BileckiW , MaćkowiakM. Epigenetic targets in schizophrenia development and therapy. Brain. Sci.13(3), 426 (2023).
   PubMed Web of Science ®Google Scholar
• Ibi D , DeLa Fuente Revenga M , KezunovicNet al. Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects. Nat. Neurosci.20(9), 1247–1259 (2017).
   PubMed Web of Science ®Google Scholar
• Swathy B , BanerjeeM. Understanding pharmaco-epigenomic response of antipsychotic drugs using genome-wide microRNA expression profile in liver cell line. Front. Mol. Neurosci.15, 786632 (2022).
   PubMed Web of Science ®Google Scholar
• Zhao B , ErwinA , XueB. How many differentially expressed genes: a perspective from the comparison of genotypic and phenotypic distances. Genomics110(1), 67–73 (2018).
   PubMed Web of Science ®Google Scholar
• Reimand J , IsserlinR , VoisinVet al. Pathway enrichment analysis and visualization of omics data using g:profiler, GSEA, Cytoscape and EnrichmentMap. Nat. Protoc.14(2), 482–517 (2019).
   PubMed Web of Science ®Google Scholar
• Adanty C , KimJ , StraussJet al. Epigenetics for drug discovery: dissecting the effect of high antipsychotic dosage and D2 blockage on peripheral DNA methylation. Pharmacopsychiatry55(4), 211–219 (2022).
   PubMedGoogle Scholar
• Adanty C , ShakeriA , StraussJ , GraffA , DeLuca V. Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia. Pharmacogenomics23(1), 5–14 (2022).
   PubMed Web of Science ®Google Scholar
• Hu M , XiaY , ZongXet al. Risperidone-induced changes in DNA methylation in peripheral blood from first-episode schizophrenia patients parallel changes in neuroimaging and cognitive phenotypes. Psychiatry Res.317, 114789 (2022).
   PubMed Web of Science ®Google Scholar
• Kinoshita M , NumataS , TajimaAet al. Effect of clozapine on DNA methylation in peripheral leukocytes from patients with treatment-resistant schizophrenia. Int. J. Mol. Sci.18(3), (2017).
   Web of Science ®Google Scholar
• Montano C , TaubMA , JaffeAet al. Association of DNA methylation differences with schizophrenia in an epigenome-wide association study. JAMA Psychiatry73(5), 506–514 (2016).
   PubMed Web of Science ®Google Scholar
• Pérez-Aldana BE , Martínez-MagañaJJ , Mayén-LoboYGet al. Clozapine long-term treatment might reduce epigenetic age through hypomethylation of longevity regulatory pathways genes. Front. Psychiatry13, 870656 (2022).
   PubMed Web of Science ®Google Scholar
• Rukova B , StanevaR , HadjidekovaS , StamenovG , MilanovaV , TonchevaD. Whole genome methylation analyses of schizophrenia patients before and after treatment. Biotechnol. Biotechnol. Equip.28(3), 518–524 (2014).
   PubMed Web of Science ®Google Scholar
• Nishioka M , BundoM , KoikeSet al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J. Hum. Genet.58(2), 91–97 (2013).
   PubMed Web of Science ®Google Scholar
• Tiwari AK , ZaiCC , LikhodiOet al. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology35(6), 1315–1324 (2010).
   PubMed Web of Science ®Google Scholar
• Tiwari A , ZaiC , LikhodiOet al. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia. Pharmacogenomics J.12(3), 260–266 (2012).
   PubMed Web of Science ®Google Scholar
• Hamdani N , TabezeJ-P , RamozNet al. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. Eur. Neuropsychopharmacol.18(1), 34–40 (2008).
   PubMed Web of Science ®Google Scholar
• Ma J , ZhaoM , ZhouWet al. Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: an updated meta-analysis. Curr. Neuropharmacol.19(10), 1780–1790 (2021).
   PubMed Web of Science ®Google Scholar
• Bakker PR , Van HartenPN , Van OsJ. Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Mol. Psychiatry13(5), 544–556 (2008).
   PubMed Web of Science ®Google Scholar
• Williams JB , MallorgaPJ , ConnPJ , PettiboneDJ , SurC. Effects of typical and atypical antipsychotics on human glycine transporters. Schizophr. Res.71(1), 103–112 (2004).
   PubMed Web of Science ®Google Scholar
• Amato D , CannevaF , CummingPet al. A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Mol. Psychiatry25(9), 2101–2118 (2020).
   PubMed Web of Science ®Google Scholar
• Moons T , DeRoo M , ClaesS , DomG. Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics12(8), 1193–1211 (2011).
   PubMed Web of Science ®Google Scholar
• Nnadi CU , MalhotraAK. Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics. Curr. Psychiatry Rep.9(4), 313–318 (2007).
   PubMedGoogle Scholar
• Li Z , HeY , HanHet al. COMT, 5-HTR2A, and SLC6A4 mRNA expressions in first-episode antipsychotic-naïve schizophrenia and association with treatment outcomes. Front. Psychiatry9, 577 (2018).
   PubMed Web of Science ®Google Scholar
• Mcevoy J , BaillieRA , ZhuHet al. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PLOS ONE8(7), e68717 (2013).
   PubMed Web of Science ®Google Scholar
• Vantaggiato C , PanzeriE , CitterioA , OrsoG , PozziM. Antipsychotics promote metabolic disorders disrupting cellular lipid metabolism and trafficking. Trends Endocrinol. Metab.30(3), 189–210 (2019).
   PubMed Web of Science ®Google Scholar
• Cussac D , DuqueyroixD , Newman-TancrediA , MillanMJ. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors. Psychopharmacology (Berl.)162(2), 168–177 (2002).
   PubMed Web of Science ®Google Scholar
• Carboni L , DomeniciE. Proteome effects of antipsychotic drugs: learning from preclinical models. Proteomics Clin. Appl.10(4), 430–441 (2016).
   PubMed Web of Science ®Google Scholar